“Marine Enterprise Day” Bioendo is launching new products

On May 24th , “Marine Enterprise Day” Bioendo is launching new products and signing complete successful contracts!


This vary day, under the witness of Xiamen Ocean Development Bureau, Xiamen Southern Ocean Research Center, Xiamen Medical College, relevant leaders of Xiamen Pharmaceutical Association and friends from well-known media reporters in Xiamen, our company signed a contract with Xiamen Pharmaceutical Association to set up endotoxin testing practice Training base; signed a contract with Xiamen Medical College (Fujian University Engineering Research Center for Marine Biomedical Resources) to cooperate in researching the breeding technology and industrial application of Tachypleus tridentatus.

In the new product launching session, our national product manager made a specific report on “ Xiamen Tachypleus tridentatus Bioscience’s new product follows the ‘optimization’, ‘reduction” and ‘replacement’ 3R principles in experimental zoology ”, and gave a detailed introduction to the leaders and guests present.

Our new listing products: overall endotoxin detection solutions and endotoxin removal solutions, endotoxin detection kits include gel clot assays, kinetic chromogenic assays, micro kinetic chromogenic assays, kinetic turbidimetric assays, end-point chromogenic assays, recombinant factor C fluorescent assays, endotoxin removal solution, and top quality of endotoxin free consumables, also endotoxin removal kit.


Talking about today’s event experience, our president Mr. Wu Shangyi said with emotion: “Thank you for the opportunity provided by the ‘Marine Enterprise Day’, which allows us to show more of the development and planning of the company.” He said that the development and growth of our company is far from without the help of the platform, through the matchmaking of Xiamen Ocean Development Bureau and the Secretariat of Xiamen Southern Ocean Research Center, our company can obtain more high-quality resources, which is very beneficial to the long-term development in the future.

With more than 40 years of deep development and more than 40 years of accumulation, Xiamen Bioendo technology Co., Ltd., as a pioneer in China’s lysate reagent industry, has now achieved independent research and development of the whole process from endotoxin test reagents, instruments to software. The company has a long way to go and is applying The development and improvement of new technologies will gradually reduce the use of Tachypleus tridentatus in China. Through technological innovation and breakthroughs, the recombinant factor lysate reagent will be developed by applying genetic recombination and synthesis technology, in order to achieve the goal of producing lysate reagents without using natural Tachypleus tridentatus blood cells in the future. Protect the “living fossil” Tachypleus tridentatus. Xiamen Bioendo was born due to “reform and opening up, and prospered because of reform and opening up”, and it has also continued to expand the international market with the national “One Belt, One Road” strategy to go abroad, and strive to become the world’s leading endotoxin detection, endotoxin A leading company in the field of solutions for removal and endotoxin-free products, it will strive to build a diversified production, learning and research enterprise, and make greater contributions to my country’s pharmaceutical industry. Let the “Made in Xiamen” Lyophilized amebocyte Lysate reagent go to the world!

Post time: May-31-2022

Leave Your Messages